nach oben

Erschienen in:

2016 | OriginalPaper | Buchkapitel

22. Primäre und sekundäre maligne Erkrankungen des Peritoneums bei alten Patienten

verfasst von : B. Rau, E. Pachmayr, W. Raue, S. Weiss

Erschienen in: Onkologische Chirurgie bei alten Patienten

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Patienten mit einer primären oder sekundären malignen Erkrankung des Peritoneums haben in Abhängigkeit des Primärtumors oder der zugrunde liegenden Histologie eine gute Prognose, wenn chirurgische Therapiemaßnahmen in das Behandlungskonzept integriert werden können. Die zytoreduktive Chirurgie (CRS) hat das Ziel, makroskopisch sichtbare Tumoren nahezu komplett zu entfernen. Hierbei sind Multiorganresektionen keine Seltenheit. Es stellt sich die Frage, ob auch für ältere Patienten mit diesem Vorgehen ähnlich gute Ergebnisse erzielt werden können.

Acherman YI, Welch LS, Bromley CM, Sugarbaker PH (2003) Clinical presentation of peritoneal mesothelioma. Tumori 89(3) 269–273PubMed

Ahmed I, Koulaouzidis A, Iqbal J, Tan WC (2008) Malignant peritoneal mesothelioma as a rare cause of ascites: a case report. J Med Case Rep 2:121. doi: 10.1186/1752-1947-2-121.121-122

Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S et al (2008) Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 15(2) 526–534CrossRefPubMed

Battifora H, Caughey W (1994) Tumors of the serosal membranes: Washington DC: Armed Forces Institute of Pathology

Benizri EI, Bereder JM, Rahili A, Bernard JL, Benchimol D (2013) Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer. Am J Surg 205(6) 668–673CrossRefPubMed

Bijelic L, Kumar AS, Stuart OA, Sugarbaker PH (2012) Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival. Gastroenterol Res Pract 2012:163284. doi: 10.1155/2012/163284. Epub;%2012 Jul 26. 163284

Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, Votanopoulos K et al (2014) Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 109(7) 740–745CrossRefPubMed

Boffetta P (2007) Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 18(6) 985–990CrossRefPubMed

Bohner H, Hummel TC, Habel U, Miller C, Reinbott S et al (2003) Predicting delirium after vascular surgery: a model based on pre- and intraoperative data. Ann Surg 238(1) 149–156PubMedPubMedCentral

Bridda A, Padoan I, Mencarelli R, Frego M (2007) Peritoneal mesothelioma: a review. MedGenMed 9(2) 32PubMed

Chua TC, Martin S, Saxena A, Liauw W, Yan TD et al (2010a) Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. Ann Surg 251(2) 323–329CrossRefPubMed

Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O et al (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20) 2449–2456CrossRefPubMed

Chua TC, Morris DL, Saxena A, Esquivel J, Liauw W et al (2011a) Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study. Ann Surg Oncol 18(6) 1560–1567CrossRefPubMed

Chua TC, Saxena A, Schellekens JF, Liauw W, Yan TD et al (2010b) Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Ann Surg 251(1) 101–106CrossRefPubMed

Chua TC, Yan TD, Deraco M, Glehen O, Moran BJ, Sugarbaker PH (2011b) Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. Br J Surg 98(1) 60–64CrossRefPubMed

Chua TC, Yan TD, Morris DL (2009) Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol 99(2) 109–113CrossRefPubMed

de la Fuente SG, Bennett KM, Pappas TN, Scarborough JE (2011) Pre- and intraoperative variables affecting early outcomes in elderly patients undergoing pancreaticoduodenectomy. HPB (Oxford) 13(12) 887–892CrossRef

De BF, Genser B, Raat H, Fischer JE, Renz-Polster H (2013) A participatory physical activity intervention in preschools: a cluster randomized controlled trial. Am J Prev Med 45(1) 64–74CrossRef

Elias D, Glehen O, Pocard M, Quenet F, Goere D et al (2010) A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix. Ann Surg 251(5) 896–901CrossRefPubMed

Esaki Y, Hirayama R, Hirokawa K (1990) A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 65(9) 2086–2090CrossRefPubMed

Esquivel J, Garcia SS, Hicken W, Seibel J, Shekitka K, Trout R (2014a) Evaluation of a new staging classification and a Peritoneal Surface Disease Severity Score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination. J Surg Oncol 110(6) 656–660CrossRefPubMed

Esquivel J, Lowy AM, Markman M, Chua T, Pelz J et al (2014b) The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Ann Surg Oncol 21(13) 4195–4201CrossRefPubMed

Gervais MK, Dube P, McConnell Y, Drolet P, Mitchell A, Sideris L (2013) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer. J Surg Oncol 108(7) 438–443CrossRefPubMed

Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X et al (2011) Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol 104(6) 692–698CrossRefPubMed

Glehen O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN (2004) Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91(6) 747–754CrossRefPubMed

Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F et al (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9) 2370–2377CrossRefPubMed

Glockzin G, Gerken M, Lang SA, Klinkhammer-Schalke M, Piso P, Schlitt HJ (2014) Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis. BMC Cancer 14:807. doi: 10.1186/1471-2407-14-807.807-814.CrossRef

Gretschel S, Estevez-Schwarz L, Hunerbein M, Schneider U, Schlag PM (2006a) Gastric cancer surgery in elderly patients. World J Surg 30(8) 1468–1474CrossRefPubMed

Gretschel S, Siegel R, Estevez-Schwarz L, Hunerbein M, Schneider U, Schlag PM (2006b) Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. Br J Surg 93(12) 1530–1535CrossRefPubMed

Hadi R, Saunders V, Utkina O, Clingan P, Kam P et al (2006) Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy. ANZ J Surg 76(3) 156–161CrossRefPubMed

Hiesmayr M, Frantal S, Schindler K, Themessl-Huber M, Mouhieddine M et al (2015) The Patient- And Nutrition-Derived Outcome Risk Assessment Score (PANDORA): Development of a Simple Predictive Risk Score for 30-Day In-Hospital Mortality Based on Demographics, Clinical Observation, and Nutrition. PLoS One 10(5) e0127316CrossRefPubMedPubMedCentral

Hildebrand P, Humke J, Oevermann E, Schloericke E, Burk C et al (2012) Influence of second or multiple tumours on the prognosis of patients with colorectal cancer. Acta Chir Iugosl 59(1) 31–38CrossRefPubMed

Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH (1998) Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology 55(2) 130–138CrossRefPubMed

Jimenez W, Sardi A, Nieroda C, Sittig M, Milovanov V et al (2014) Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 21(13) 4218–4225CrossRefPubMed

Jin S, Cao S, Cao J, Shen J, Hu J et al (2015) Predictive factors analysis for malignant peritoneal mesothelioma. J Gastrointest Surg 19(2) 319–326CrossRefPubMed

Kelly CL, Thomson K, Wagner AP, Waters JP, Thompson A et al (2015) Investigating the widely held belief that men and women with learning disabilities receive poor quality healthcare when admitted to hospital: a single-site study of 30-day readmission rates. J Intellect Disabil Res 10

Kim KW, Chow O, Parikh K, Blank S, Jibara G et al (2014) Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy. Am J Surg 207(1) 78–83CrossRefPubMed

Klaver YL, Chua TC, de Hingh IH, Morris DL (2012) Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis. J Surg Oncol 105(2) 113–118CrossRefPubMed

Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D et al (2014) Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. Br J Surg 101(13) 1758–1765CrossRefPubMed

Langard S (2005) Nordic experience: expected decline in the incidence of mesotheliomas resulting from ceased exposure? Med Lav 96(4) 304–311PubMed

Lawlor PG, Bush SH (2015) Delirium in patients with cancer: assessment, impact, mechanisms and management. Nat Rev Clin Oncol 12(2) 77–92CrossRefPubMed

Liu X, Cai H, Sheng W, Wang Y (2012) Long-term results and prognostic factors of gastric cancer patients with microscopic peritoneal carcinomatosis. PLoS One 7(5) e37284CrossRefPubMedPubMedCentral

Luger TJ, Kammerlander C, Luger MF, Kammerlander-Knauer U, Gosch M (2014) Mode of anesthesia, mortality and outcome in geriatric patients. Z Gerontol Geriatr 47(2) 110–124CrossRefPubMed

Manzini VP, Recchia L, Cafferata M, Porta C, Siena S et al (2010) Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol 21(2) 348–353CrossRef

Marmor S, Portschy PR, Tuttle TM, Virnig BA (2015) The rise in appendiceal cancer incidence: 2000–2009. J Gastrointest Surg 19(4) 743–750CrossRefPubMed

McWilliam C, Copeland JR, Dewey ME, Wood N (1988) The Geriatric Mental State Examination as a case-finding instrument in the community. Br J Psychiatry 152:205-8. 205–208CrossRefPubMed

Milovanov V, Sardi A, Ledakis P, Aydin N, Nieroda C et al (2015) Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA). Eur J Surg Oncol 41(5) 707–712CrossRefPubMed

Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE et al (2003) Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 14(8) 791–803CrossRefPubMed

Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramaniam A (2015) The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Colorectal Dis 10

Neuman HB, Weiss JM, Leverson G, O′Connor ES, Greenblatt DY et al (2013) Predictors of short-term postoperative survival after elective colectomy in colon cancer patients >/= 80 years of age. Ann Surg Oncol 20(5) 1427–1435CrossRefPubMedPubMedCentral

Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A (2015) Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol 33(13) 1453–1459CrossRefPubMed

Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J et al (2012) Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann Surg 256(5) 763–771CrossRefPubMed

Nitsche U, Spath C, Muller TC, Maak M, Janssen KP et al (2014) Colorectal cancer surgery remains effective with rising patient age. Int J Colorectal Dis 29(8):971–979CrossRefPubMedPubMedCentral

Panarelli NC, Yantiss RK (2011) Mucinous neoplasms of the appendix and peritoneum. Arch Pathol Lab Med 135(10) 1261–1268CrossRefPubMed

Pelz JO, Chua TC, Esquivel J, Stojadinovic A, Doerfer J et al (2010) Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer 10:689. doi: 10.1186/1471-2407-10-689.689-10.CrossRefPubMedPubMedCentral

Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T et al (2014) The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol 110(7) 779–785CrossRefPubMed

Price B, Ware A (2009) Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol 39(7) 576–588CrossRefPubMed

Randle RW, Griffith KF, Fino NF, Swett KR, Stewart JH et al (2015) Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res (15) 10

Rau B (2014) [Prospective multicentric phase III study] Z Gastroenterol 52(3) 262PubMed

Razenberg LG, van Gestel YR, Creemers GJ, Verwaal VJ, Lemmens VE, de Hingh IH (2015a) Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands. Eur J Surg Oncol 41(4) 466–471CrossRefPubMed

Razenberg LG, van Gestel YR, Lemmens VE, de Wilt JH, Creemers GJ, de Hingh IH (2015b) The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study. Clin Colorectal Cancer (15) 10

Reu S, Neumann J, Kirchner T (2012) [Mucinous neoplasms of the vermiform appendix, Pseudomyxoma peritonei, and the new WHO classification] Pathologe 33(1) 24–30PubMed

Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353(15) 1591–1603CrossRefPubMed

Ronnett BM, Seidman JD (2003) Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol 27(5) 650–657CrossRefPubMed

Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P et al (2008) Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. Eur J Surg Oncol 34(11) 1246–1252CrossRefPubMed

Scripcariu V, Dajbog E, Radu I, Ferariu D, Pricop A et al (2007) [Malignant peritoneal mesothelioma tumours. Evolution, treatment, prognosis] Rev Med Chir Soc Med Nat Iasi 111(3) 673–677PubMed

Smeenk RM, Bruin SC, van Velthuysen ML, Verwaal VJ (2008) Pseudomyxoma peritonei. Current Problems in Surgery 45(8) 527–575CrossRefPubMed

Spiliotis JD, Halkia E, Boumis VA, Vassiliadou DT, Pagoulatou A, Efstathiou E (2014) Cytoreductive surgery and HIPEC for peritoneal carcinomatosis in the elderly. Int J Surg Oncol 2014:987475. 987475

Statistisches Bundesamt (2014) Demografie. Internet https://www.destatis.de/SiteGlobals/Forms/Suche/Servicesuche_Formular.html;jsessionid=22DC1361C0C495AC7323B793774B53B9.cae1?nn=50926&resourceId=47156&input_=50926&pageLocale=DE&searchUrl=http%3A%2F%

Statistisches Bundesamt (2015) Gesundheitsberichterstattung des Bundes. Wiesbaden, www.gbe-bund.de

Sugarbaker PH, Welch LS, Mohamed F, Glehen O (2003) A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 12 (3) 605-21, xiCrossRefPubMed

Suh DH, Kim JW, Kim HS, Chung HH, Park NH, Song YS (2014) Pre- and intra-operative variables associated with surgical complications in elderly patients with gynecologic cancer: the clinical value of comprehensive geriatric assessment. J Geriatr Oncol 5(3) 315–322CrossRefPubMed

Takata Y, Ansai T, Soh I, Awano S, Nakamichi I et al (2014) Cognitive function and 10 year mortality in an 85 year-old community-dwelling population. Clin Interv Aging 9: 1691-9. doi: 10.2147/CIA.S64107. eCollection;%2014. 1691–1699

Tempfer CB, Celik I, Solass W, Buerkle B, Pabst UG et al (2014) Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. Gynecol Oncol 132(2) 307–311CrossRefPubMed

Thomassen I, van Gestel YR, Aalbers AG, van Oudheusden TR, Wegdam JA et al (2014) Peritoneal carcinomatosis is less frequently diagnosed during laparoscopic surgery compared to open surgery in patients with colorectal cancer. Eur J Surg Oncol 40(5) 511–514CrossRefPubMed

Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA (2012) Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg 215(3) 412–417CrossRefPubMedPubMedCentral

Weill H, Hughes JM, Churg AM (2004) Changing trends in US mesothelioma incidence. Occup Environ Med 61(5) 438–441CrossRefPubMedPubMedCentral

Welch LS, Acherman YI, Haile E, Sokas RK, Sugarbaker PH (2005) Asbestos and peritoneal mesothelioma among college-educated men. Int J Occup Environ Health 11(3) 254–258CrossRefPubMed

Yan TD, Chu F, Links M, Kam PC, Glenn D, Morris DL (2006a) Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival. Eur J Surg Oncol 32(10) 1119–1124CrossRefPubMed

Yan TD, Popa E, Brun EA, Cerruto CA, Sugarbaker PH (2006b) Sex difference in diffuse malignant peritoneal mesothelioma. Br J Surg 93(12) 1536–1542CrossRefPubMed

Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL et al (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18(6) 1575–1581CrossRefPubMedPubMedCentral

Yang XJ, Li Y, Yonemura Y (2010) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center. J Surg Oncol 101(6) 457–464CrossRefPubMed

Yonemura Y, Elnemr A, Endou Y, Hirano M, Mizumoto A et al (2010) Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol 2(2) 85–97CrossRefPubMedPubMedCentral

Titel: Primäre und sekundäre maligne Erkrankungen des Peritoneums bei alten Patienten
verfasst von: B. Rau
E. Pachmayr
W. Raue
S. Weiss
Verlag: Springer Berlin Heidelberg
Buch: Onkologische Chirurgie bei alten Patienten
Print ISBN: 978-3-662-48711-2

Electronic ISBN: 978-3-662-48712-9

Copyright-Jahr: 2016
DOI: https://doi.org/10.1007/978-3-662-48712-9_22

Neu im Fachgebiet AINS

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

22. Primäre und sekundäre maligne Erkrankungen des Peritoneums bei alten Patienten

Zusammenfassung

Neu im Fachgebiet AINS

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet AINS

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS